Dosage aspects of danazol therapy in the treatment of endometriosis.

Postgraduate medical journal · 1979 · vol. 55 Suppl 5 , pp. 7–9 · PMID:395524 · PMC2425544 · W2473205615
article OA: green CC0 ⤵ 7 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed
AI-generated summary by gemini-2.5-flash-lite, 2026-06-08

Danazol effectively treats endometriosis, but optimal dosage requires individual trial and error starting from recommended initial doses due to variable patient response and requirements.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Danazol is effective in the treatment of endometriosis. Individual patient response is very variable as is dosage requirement. The appropriate dose for maintenance therapy for any particular patient is best determined by a trial and error method, starting with a recommended initial dosage. Side effects are slight.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Danazol Endometriosis Ovarian Neoplasms Pregnadienes Adolescent Adult Clinical Trials as Topic Danazol Danazol Danazol Drug Administration Schedule Endometriosis Female Humans Ovarian Neoplasms Pregnadienes

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (7)

SciLite annotations

chemicals 2
danazol danazol

Source provenance

europepmc
last seen: 2026-09-04T06:17:57.233406+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-14T05:58:48.767648+00:00
scilite
last seen: 2026-05-18T04:57:49.680383+00:00
License: CC0 · commercial use OK